Investing

Monsanto, Rite Aid and More Earnings Kicking Off the New Year

The year is coming to an end and the markets are holding near all-time highs — not a bad way to start 2018. While most people are taking vacations during this time, we might not expect to see many companies reporting earnings until later in January. However there are a few big names coming out this week to kick off the new year.

24/7 Wall St. has put together a preview of some of the top companies reporting their latest results in the coming week. We have included the consensus earnings estimates from Thomson Reuters, as well as the stock price and trading history for these companies ahead of the report.

Keep in mind that estimates may change ahead of the report.

Rite Aid Corp. (NYSE: RAD) fiscal third-quarter report is scheduled for late on Wednesday. Consensus estimates are calling for a net loss of $0.02 per share and $7.45 billion in revenue. The shares closed trading at $1.97 apiece on Friday. The consensus price target is $2.11, and the 52-week trading range is $1.38 to $8.77.

Monsanto Co. (NYSE: MON) is expected to share its most recent quarterly numbers first thing Thursday. Analysts are looking for $0.42 in earnings per share (EPS) and $2.77 billion in revenue. Shares were last seen at $116.78 apiece, in a 52-week range of $104.77 to $122.80. The consensus price target is $125.18.

Walgreens Boots Alliance Inc. (NASDAQ: WBA) also is set to release its most recent quarterly results Thursday morning. The consensus forecast calls for $1.26 in EPS on $30.42 billion in revenue. Shares ended last week at $72.62. The consensus price target is $85.67, and the 52-week range is $63.82 to $89.69.

And Constellation Brands Inc. (NYSE: STZ) will report its fiscal third-quarter results before Friday’s opening bell. The consensus estimates are EPS of $1.88 and revenue of $1.87 billion. Shares closed most recently at $223.30, in a 52-week range of $144.00 to $229.41. The consensus price target is $237.58.

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.